前收市價 | 5.76 |
開市 | 5.48 |
買盤 | 4.85 x 無 |
賣出價 | 5.06 x 無 |
今日波幅 | 5.48 - 5.48 |
52 週波幅 | 2.06 - 6.98 |
成交量 | |
平均成交量 | 0 |
市值 | 無 |
Beta 值 (5 年,每月) | 無 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | 無 |
業績公佈日 | 2024年5月08日 - 2024年5月13日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 無 |
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2023 Earnings Call Transcript March 27, 2024 Syros Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to Syros Pharmaceuticals Fourth Quarter and Full Year 2023 Financial Results Conference Call. […]
A company’s size does not necessarily dictate the size of it’s returns. On the contrary, if their jobs are done correctly, these penny stocks with potential can generate exponential returns that will undoubtedly benefit your investments. These penny stocks with potential can be beneficial for generating returns. Let’s analyze the following so you can consider adding them to your portfolio. Asure (ASUR) Source: Shutterstock Asure Software (NASDAQ:ASUR) produces cloud-based software solutions that
If the first rule in the film “Fight Club” is to not talk about fight club, then the same rule applies to penny stocks with potential: you do not talk about these penny stocks with upside. To clarify, the ideas present tremendous risks. You could see massive rewards but if we’re being completely honest, you’re likelier to see devastating losses. It’s a good time to share with you all what my football coach once told us. When some of my teammates complained about certain protective gear slowing t